Cargando…
Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma
Surgery with the assistance of conventional radiotherapy, chemotherapy and immunotherapy is the basis for head and neck squamous cell carcinoma (HNSCC) treatment. However, with these treatment modalities, the recurrence and metastasis of tumors remain at a high level. Increasingly, the evidence indi...
Autores principales: | Wang, Han-Qi, Fu, Ruxing, Man, Qi-Wen, Yang, Guang, Liu, Bing, Bu, Lin-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052000/ https://www.ncbi.nlm.nih.gov/pubmed/36983174 http://dx.doi.org/10.3390/jcm12062173 |
Ejemplares similares
-
Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma
por: Sun, Zhi-Jun, et al.
Publicado: (2016) -
Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017) -
Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma
por: Li, Su-Ran, et al.
Publicado: (2022) -
Advances in the management of squamous cell carcinoma of the head and neck
por: Machiels, Jean-Pascal, et al.
Publicado: (2014) -
Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Zheng, Shuwen, et al.
Publicado: (2023)